Long-term prognosis of 69 patients with dermatomyositis or polymyositis
- PMID: 8809440
Long-term prognosis of 69 patients with dermatomyositis or polymyositis
Abstract
Objectives: To assess the long-term prognosis of dermatomyositis and pol myositis.
Methods: 69 patients with dermatomyositis or polymyositis were selected according to the diagnostic criteria of Bohan and Peter and were followed up for a minimum of 6.3 years (for surviving patients) (mean 11.6 years). Clinical and biological features, and pulmonary and muscle parameters were considered as prognostic factors for death. Functional disability was assessed using a 4-stage grading system.
Results: 30 deaths (43.5%) occurred mainly due to cardiovascular (8), pulmonary (8), carcinomatous (5) and iatrogenic complications (5). Survival rates were 82.6% at 1 year, 73.9% at 2.66, 7% at 5 and 55.4% at 9. Significant prognostic factors for death (Cox model with time-dependent covariates) were old age (p < 0.0001), dysphonia (p < 0.001), pulmonary interstitial fibrosis (p < 0.02), absence of dysphagia (p < 0.02) and asthenia-anorexia (p < 0.05). Dermatomyositis and polymyositis subgroups had slightly different significant prognostic factors for death: old age, cancer, pulmonary interstitial fibrosis and asthenia-anorexia for dermatomyositis; old age, failure to improve muscle strength in response to treatment after one month, and the absence of myalgia as presenting symptom for polymyositis. At the end of the follow-up, 33/39 surviving patients (84.6%) had no or insignificant muscular disability, whereas 3 children were bedridden due to generalized calcinosis.
Conclusions: High mortality occurred in the first year, and the survival rate decreased continually up to 9 years. The main prognostic factor for death is old age, but dermatomyositis and polymyositis must be considered separately. General features (pulmonary fibrosis, cancer, asthenia-anorexia) are involved in dermatomyositis, whereas muscular symptoms are the most significant in polymyositis. The long-term functional prognosis was fairly good, except for generalized calcinosis, which tended to occur in childhood dermatomyositis.
Similar articles
-
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.Autoimmun Rev. 2014 Oct;13(10):1048-54. doi: 10.1016/j.autrev.2014.08.023. Epub 2014 Aug 23. Autoimmun Rev. 2014. PMID: 25183232
-
Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors.Mod Rheumatol. 2016;26(1):115-20. doi: 10.3109/14397595.2015.1054081. Epub 2015 Jun 13. Mod Rheumatol. 2016. PMID: 26011440
-
Long-term follow-up of 76 Iranian patients with idiopathic inflammatory myopathies.Int J Rheum Dis. 2018 Aug;21(8):1627-1633. doi: 10.1111/1756-185X.13352. Int J Rheum Dis. 2018. PMID: 30146744
-
Hematological malignancy associated with polymyositis and dermatomyositis.Autoimmun Rev. 2012 Jul;11(9):615-20. doi: 10.1016/j.autrev.2011.10.024. Epub 2011 Oct 30. Autoimmun Rev. 2012. PMID: 22079677 Review.
-
The heart in dermatomyositis and polymyositis.Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv18-21. doi: 10.1093/rheumatology/kel311. Rheumatology (Oxford). 2006. PMID: 16980718 Review.
Cited by
-
Clinical characteristics and outcomes of juvenile and adult dermatomyositis.J Korean Med Sci. 2009 Aug;24(4):715-21. doi: 10.3346/jkms.2009.24.4.715. Epub 2009 Jul 30. J Korean Med Sci. 2009. PMID: 19654958 Free PMC article.
-
Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain.Rheumatol Int. 2017 Nov;37(11):1853-1861. doi: 10.1007/s00296-017-3799-x. Epub 2017 Sep 2. Rheumatol Int. 2017. PMID: 28866745
-
Increased Serum LIGHT Levels Correlate with Disease Progression and Severity of Interstitial Pneumonia in Patients with Dermatomyositis: A Case Control Study.PLoS One. 2015 Oct 8;10(10):e0140117. doi: 10.1371/journal.pone.0140117. eCollection 2015. PLoS One. 2015. PMID: 26448572 Free PMC article.
-
Severe Cutaneous Findings in a Woman with Dermatomyositis.Clin Pract Cases Emerg Med. 2019 May 20;3(3):222-225. doi: 10.5811/cpcem.2019.3.41058. eCollection 2019 Aug. Clin Pract Cases Emerg Med. 2019. PMID: 31403096 Free PMC article.
-
Paraneoplastic myopathy in pancreatic cancer: a case report and literature review.J Community Hosp Intern Med Perspect. 2021 Nov 15;11(6):847-851. doi: 10.1080/20009666.2021.1982487. eCollection 2021. J Community Hosp Intern Med Perspect. 2021. PMID: 34804404 Free PMC article.